Cardiovascular calcification heterogeneity in chronic kidney disease
JD Hutcheson, C Goettsch - Circulation research, 2023 - Am Heart Assoc
Patients with chronic kidney disease (CKD) exhibit tremendously elevated risk for
cardiovascular disease, particularly ischemic heart disease, due to premature vascular and …
cardiovascular disease, particularly ischemic heart disease, due to premature vascular and …
[HTML][HTML] Osteoporosis and fragility fractures: currently available pharmacological options and future directions
HP Dimai, A Fahrleitner-Pammer - Best practice & research Clinical …, 2022 - Elsevier
Osteoporosis is a systemic skeletal disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility …
microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility …
Curcumin delivery using tetrahedral framework nucleic acids enhances bone regeneration in osteoporotic rats
L Bai, M Feng, Q Li, Y Zhao, G Zhang, Z Cai… - Chemical Engineering …, 2023 - Elsevier
Osteoporosis is an age-related disorder characterized by progressive bone loss and
impaired bone regeneration following surgery. The key to the treatment of osteoporosis is …
impaired bone regeneration following surgery. The key to the treatment of osteoporosis is …
Romosozumab in osteoporosis: yesterday, today and tomorrow
D Wu, L Li, Z Wen, G Wang - Journal of Translational Medicine, 2023 - Springer
Osteoporosis is a systemic bone disease characterized by low bone mass,
microarchitectural deterioration, increased bone fragility, and fracture susceptibility. It …
microarchitectural deterioration, increased bone fragility, and fracture susceptibility. It …
Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis
A Aguilar, L Gifre, P Ureña-Torres… - Frontiers in …, 2023 - frontiersin.org
Chronic kidney disease (CKD) is a highly prevalent disease that has become a public health
problem. Progression of CKD is associated with serious complications, including the …
problem. Progression of CKD is associated with serious complications, including the …
One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: An observational study
T Saito, M Mizobuchi, T Kato, T Suzuki… - Calcified Tissue …, 2023 - Springer
There is limited evidence on the use of romosozumab (ROMO) in the treatment of
osteoporosis in patients on hemodialysis (HD); thus, we aimed to investigate this topic. This …
osteoporosis in patients on hemodialysis (HD); thus, we aimed to investigate this topic. This …
Is adynamic bone always a disease? Lessons from patients with chronic kidney disease
Renal osteodystrophy (ROD) is a common complication of end-stage kidney disease that
often starts early with loss of kidney function, and it is considered an integral part in …
often starts early with loss of kidney function, and it is considered an integral part in …
Influence of renal function on pharmacokinetics, pharmacodynamics, and safety of a single dose of romosozumab
CP Hsu, J Maddox, G Block… - The Journal of Clinical …, 2022 - Wiley Online Library
We evaluated the pharmacokinetics, pharmacodynamics, and safety of a single
subcutaneous dose of romosozumab 210 mg, a monoclonal antibody against sclerostin, in …
subcutaneous dose of romosozumab 210 mg, a monoclonal antibody against sclerostin, in …
All the might of the osteocyte: emerging roles in chronic kidney disease
Osteocytes are the most abundant type of bone cell and play crucial roles in bone health.
Osteocytes sense mechanical stress and orchestrate osteoblasts and osteoclasts to …
Osteocytes sense mechanical stress and orchestrate osteoblasts and osteoclasts to …
Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
P Hong, R Liu, S Rai, JJ Liu, YM Zhou… - Journal of Orthopaedic …, 2023 - Springer
Purpose Osteoporosis poses a challenge to public health, causing fragility fractures,
especially in postmenopausal women. Abaloparatide (ABL) is an effective anabolic agent to …
especially in postmenopausal women. Abaloparatide (ABL) is an effective anabolic agent to …